RHOA and melanoma: The results show that at the basal level, independently from any cell surface receptor engagement, R200K and Q226L Gα13 mutants hyperactivate RHOA in both the B16-F0 melanoma cell line (Fig. 5a) and primary melanocytes (Supplementary Fig. 3c).